Drug Controller General of India

Hetero's Tocilizumab biosimilar gets emergency use authorisation from DCGI for COVID treatment

Hetero's biologics arm, Hetero Biopharma will manufacture the drug at its dedicated biologics facility, based at Jadcherla in Hyderabad.

published on : 6th September 2021

Zydus Cadila's Covid vaccine gets approval, to be administered to children in India

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response.

published on : 20th August 2021

Pfizer, Johnson and Johnson yet to apply for license of COVID-19 vaccines in India: Sources

Another giant pharma company Moderna is supposed to donate seven million doses to India from the United States under Covax is still pending.

published on : 15th July 2021

'India to make 850 millon Sputnik doses annually': Vaccine makers lay out production plans after getting DGCI approval

The Drug Controller General of India (DCGI) has registered the vaccine under the emergency use authorisation procedure.

published on : 13th April 2021

Indian government may blacklist eight Chinese pharma firms over quality issues

Sources said that with government's action against the China firms, India may witness a shortage of medicines, including for vital diseases such as cancer, for a couple of months.

published on : 7th January 2018